Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England.
Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England.
复制标题
DOI：
10.1093/bjs/znab426
复制
发表时间：
2022-02-01
期刊：
影响因子：
--
通讯作者：
Sweetland S
中科院分区：
文献类型：
--
作者：
Gathani T;Reeves G;Dodwell D;Horgan K;Kearins O;Kan SW;Sweetland S
人们对为应对COVID-19大流行而采取的措施（包括暂停国家筛查计划）对英国国民医疗服务体系（NHS）癌症服务的影响表示严重关切。关于癌症等待时间的数据显示了2020年上半年大流行对乳腺癌服务转诊和治疗活动的影响2。通过使用英格兰3的常规国家数据，报告了2020年和2021年的乳腺癌服务转诊和治疗活动，并与2019年进行了比较。在有数据的情况下，报告了英国按年龄、种族和贫困情况进行的紧急转诊和治疗活动。数据提取自两个公开的英文数据集：癌症等待时间（CWT）数据集3和COVID-19癌症公平数据包4。CWT数据集报告了每月从初级保健到二级保健的紧急和常规乳腺癌转诊的计数，以及每月乳腺癌首次治疗的计数。首次治疗计数是衡量新诊断数量的替代指标，包括任何诊断途径的侵入性（icd - 10c50）和非侵入性（icd - 10d05）乳腺癌，包括约占乳腺癌诊断40%的常规筛查。对于来自CWT数据集的转诊和治疗数据，每月计数分为2019年1月至2021年6月的五个半年时间段，并给出了2020年和2021年半年计数与2019年相应半年计数的比率（表1）。《2019冠状病毒病癌症公平性数据包》提供了按年龄、种族和贫困状况分列的紧急转诊和首次治疗计数的额外信息（见表S1和表S2）。假设2019年是一个正常的年份，那么在2020年上半年，紧急转诊减少了33%，常规转诊减少了40%；然而，在2020年下半年，紧急转诊增加了7%，常规转诊减少了20%。在2021年上半年，紧急转诊的数量增加了10%，常规转诊的数量增加了10%
Significant concerns have been raised about the impact of measures taken to manage the COVID-19 pandemic on the National Health Service (NHS) cancer services, including pausing of national screening programmes 1. Data on cancer waiting times have shown the effect of the pandemic on breast cancer service referral and treatment activity in the first half of 2020 2. By using routinely available national data for England 3, breast cancer service referral and treatment activity in 2020 and 2021, compared with those in 2019, are reported here. Where data are available, urgent referral and treatment activity in England by age, ethnicity, and deprivation are reported 4. Data were extracted from two publicly available English data sets: the Cancer Waiting Times (CWT) data set 3 and the COVID-19 Cancer Equity Data Packs 4. The CWT data set reports monthly counts of urgent and routine breast referrals from primary to secondary care, and monthly counts of first treatments for breast cancer. The first treatment counts are a surrogate measure of the number of new diagnoses and include invasive (ICD-10 C50) and non-invasive (ICD-10 D05) breast cancer from any route to diagnosis, including routine screening which accounts for approximately 40 per cent of breast cancer diagnoses. For referral and treatment data from the CWT data set, the monthly counts were grouped into five half-year time periods from January 2019 to June 2021, and present half-year counts and the ratio of half-year counts in 2020 and 2021 to the corresponding half-year counts in 2019 (Table 1). The COVID-19 Cancer Equity Data Packs provide additional information by age, ethnicity, and deprivation for urgent referrals and first treatment counts (see Tables S1 and S2).Assuming 2019 represents a normal year for comparison, in the first half of 2020, there were 33 per cent fewer urgent, and 40 per cent fewer routine, referrals; however, in the second half of 2020, there were 7 per cent more urgent referrals and 20 per cent fewer routine referrals. During the first half of 2021, the volume of urgent referrals was 10 per cent higher and the volume of routine referrals
影响因子：
8.8
作者：
Gathani T;Clayton G;MacInnes E;Horgan K
通讯作者：
Horgan K